Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Dorey

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature Biotechnology|July 13, 2010
French IPO spateEmma Dorey
Nature Biotechnology|April 9, 2009
Competition intensifies around hepatitis CEmma Dorey
Nature Biotechnology|June 4, 2002
Genta strikes bumper deal with AventisEmma Dorey
Nature Biotechnology|January 6, 2004
Nasdaq dilutes its biotech indexEmma Dorey
Nature Biotechnology|May 19, 2004
'Spinning in': a new concept for technology transfer?Emma Dorey
Nature Biotechnology|August 12, 2009
Awards bridge 'valley of death'Emma Dorey
Nursing Older People|January 31, 2007
Improving outcomesEmma Dorey
Nature Biotechnology|November 9, 2010
Bristol-Myers Squibb reaps biologics in ZymoGenetics windfallEmma Dorey
Nature Biotechnology|June 11, 2009
Phase zero launchEmma Dorey
Nature Biotechnology|July 13, 2010
Merck ditches biogenericEmma Dorey
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature Biotechnology|July 13, 2010
French IPO spateEmma Dorey
Nature Biotechnology|April 9, 2009
Competition intensifies around hepatitis CEmma Dorey
Nature Biotechnology|June 4, 2002
Genta strikes bumper deal with AventisEmma Dorey
Nature Biotechnology|January 6, 2004
Nasdaq dilutes its biotech indexEmma Dorey
Nature Biotechnology|May 19, 2004
'Spinning in': a new concept for technology transfer?Emma Dorey
Nature Biotechnology|August 12, 2009
Awards bridge 'valley of death'Emma Dorey
Nursing Older People|January 31, 2007
Improving outcomesEmma Dorey
Nature Biotechnology|November 9, 2010
Bristol-Myers Squibb reaps biologics in ZymoGenetics windfallEmma Dorey
Nature Biotechnology|June 11, 2009
Phase zero launchEmma Dorey
Nature Biotechnology|July 13, 2010
Merck ditches biogenericEmma Dorey
Pageof 2